CareView Communications (CRVW) Total Non-Current Liabilities (2010 - 2026)
CareView Communications' (CRVW) quarterly Total Non-Current Liabilities came in at $822410.0 in Q2 2026, down 17.76% year-over-year from $1.0 million in Q2 2025, and down 12.72% quarter-over-quarter from $942239.0 in Q1 2026.
Powered by 
Analysis
CareView Communications (CRVW) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
CareView Communications has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $822410.0 for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 17.76% year-over-year to $822410.0; the TTM figure through Jun 2026 stood at $822410.0 (down 17.76% YoY), while the FY2025 annual figure was $961692.0, up 277.69% from the prior year.
- Total Non-Current Liabilities came in at $822410.0 for Q2 2026 at CareView Communications, down from $942239.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $85.7 million in Q1 2022 to a low of $99082.0 in Q2 2024.
- Average Total Non-Current Liabilities over 5 years is $9.8 million, with a median of $822410.0 recorded in 2026.
- Year-over-year, Total Non-Current Liabilities tumbled 99.67% in 2023 and surged 909.33% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $14.5 million in 2022, then sank by 97.81% to $318006.0 in 2023, then declined by 19.93% to $254628.0 in 2024, then soared by 277.69% to $961692.0 in 2025, then retreated by 14.48% to $822410.0 in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $822410.0 in Q2 2026, $942239.0 in Q1 2026, and $961692.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 985.45 Mn |
| 10 | CareView Communications | 23.36 Mn | 21.44 Mn | - | 822,410.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 822,410.00 |
| Mar 31, 2026 | 942,239.00 |
| Dec 31, 2025 | 961,692.00 |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 373,081.00 |
| Dec 31, 2024 | 254,628.00 |
| Sep 30, 2024 | 287,143.00 |
| Jun 30, 2024 | 99,082.00 |
| Dec 31, 2023 | 318,006.00 |
| Sep 30, 2023 | 334,462.00 |
| Jun 30, 2023 | 242,345.00 |
| Mar 31, 2023 | 286,227.00 |
| Dec 31, 2022 | 14.53 Mn |
| Sep 30, 2022 | 29.07 Mn |
| Jun 30, 2022 | 30.47 Mn |
| Mar 31, 2022 | 85.69 Mn |
| Dec 31, 2021 | 28.45 Mn |
| Sep 30, 2021 | 27.47 Mn |
| Jun 30, 2021 | 26.51 Mn |